British Association of Dermatologists’ guidelines for the management of lichen sclerosus 2010

@article{Neill2010BritishAO,
  title={British Association of Dermatologists’ guidelines for the management of lichen sclerosus 2010},
  author={S. Mc Neill and F M Lewis and F. M. Tatnall and Neil H. Cox},
  journal={British Journal of Dermatology},
  year={2010},
  volume={163}
}
This is an updated guideline prepared for the British Association of Dermatologists’ (BAD) Clinical Standards Unit, made up of the Therapy & Guidelines Subcommittee (T&G) and the Audit & Clinical Standards Subcommittee (A&CS). Members of the Clinical Standards Unit are: M.J. Tidman (Chairman T&G), L.C. Fuller (Chairman A&CS), N.J. Levell, P.D. Yesudian, J. Lear, J. Hughes, A.J. McDonagh, S. Punjabi, N. Morar, S. Wagle (British National Formulary), S.E. Hulley (British Dermatological Nursing… 

Topics from this paper

Paper Mentions

Interventional Clinical Trial
The aim of this study is to demonstrate the safety and effectiveness of mixed methylene blue compound Injection for the treatment of nonneoplastic epithelial disorders(NNEDS) of vulva… 
ConditionsNonneoplastic Epithelial Disorders of Vulva
InterventionDrug
A Survey of Experts Regarding the Treatment of Adult Vulvar Lichen Sclerosus
  • A. Selk
  • Medicine
    Journal of lower genital tract disease
  • 2015
TLDR
Lichen sclerosus management varies among experts, and Variations exist between physician specialties and between those practicing in different geographic locations.
2014 UK national guideline on the management of vulval conditions
TLDR
This guideline offers recommendation on the management of a range of vulval disorders which may present to genitourinary medicine (GUM) clinics, including dermatoses, pain syndromes and pre-malignant conditions.
Childhood Lichen Sclerosus—A Challenge for Clinicians
TLDR
The background and the long‐term course of childhood LS were defined and it was revealed that three of six patients who were asymptomatic at the end of the registery study follow‐up experienced a recurrence of symptoms.
The management of lichen sclerosus in a genitourinary medicine setting: a 12-month retrospective case-notes review
  • R. Challenor
  • Medicine
    International journal of STD & AIDS
  • 2015
TLDR
It is surprising that there is still no evidence to direct long-term management of lichen sclerosus in women seen during a 12-month period andAutoimmune conditions were seven times more frequent overall compared with United Kingdom prevalences.
The clinical spectrum of lichen sclerosus in male patients - a retrospective study.
TLDR
The results showed that the clinical spectrum was wide and more than half of the patients reported that LS had a negative impact on their sexual health, emphasising the need for follow-up of male patients with LS.
Evidence‐based (S3) Guideline on (anogenital) Lichen sclerosus
TLDR
The gold standard for treatment remains potent to very potent topical steroids; however, mild and moderate disease in boys and men may be cured by circumcision.
Evidence‐based (S3) Guideline on (anogenital) Lichen sclerosus
TLDR
The gold standard for treatment remains potent to very potent topical steroids; however, mild and moderate disease in boys and men may be cured by circumcision.
A Review Article on Lichen Sclerosus, Affecting Ano-Genital Area in Females
TLDR
The disease epidemiology, pathogenesis, clinical features, complications, differential diagnosis, diagnostic methods, histopathology, psychosocial impact, and treatment options are reviewed.
Current views on the diagnosis and treatment of genital lichen sclerosus
TLDR
The gold standard for the treatment of LS is the use of strong and very strong topical corticosteroids, but mild and moderate forms of the disease in males can be treated by surgical methods such as circumcision.
Male and female genital lichen sclerosus. Clinical and functional classification criteria
TLDR
Lichen sclerosus is clinically described differently in females and in males and every form of LS is put into one of two stages according to the degree of severity: early and late stages.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 161 REFERENCES
The British Association of Dermatologists therapeutic guidelines: can we AGREE?
TLDR
Comment is to comment on two major issues that will affect the BAD guidelines process, and to update readers on how the Therapy Guidelines and Audit Subcommittee of the BAD will address these.
Writing a British Association of Dermatologists clinical guideline: an update on the process and guidance for authors
TLDR
This advice is aimed at the authors of British Association of Dermatologists (BAD) guidelines for developing a new topic for a BAD guideline, aimed at dermatologists and nurses working in clinical dermatological practice.
Guidelines for the management of lichen sclerosus
TLDR
These guidelines for the management of lichen sclerosus present evidence‐based guidance for treatment, with identification of the strength of evidence available at the time of preparation, and a brief overview of epidemiological aspects, diagnosis and investigation.
[Genital lichen sclerosus].
TLDR
A relatively low recovery rate of genital lichen sclerosus was found in the study, which may be related to an inadequate follow up added to an insufficient treatment adherence.
Topical tacrolimus in the management of lichen sclerosus
TLDR
It is argued that tacrolimus should be used with caution in tertiary care, ideally with input from both a gynaecological and dermatological consultant with all women under long-term follow up, and in some women, serum levels do reach significant levels.
Does treatment of vulvar lichen sclerosus influence its prognosis?
TLDR
Topical ultrapotent steroid is an effective treatment for vulvar lichen sclerosus, giving relief of symptoms in most and completely reversing the skin changes in approximately one fifth of patients.
Clinical features of lichen sclerosus in men attending a department of genitourinary medicine
TLDR
LS is not uncommon in men presenting to a GUM department, and is often asymptomatic, but the disease responds well to potent topical steroids allowing the normal anatomy to be preserved in most individuals.
Topical immunosuppressants, genital lichen sclerosus and the risk of squamous cell carcinoma: a case report.
TLDR
It may be safest to restrict the use of topical immunosuppressives to patients with LS who are unable to use topical corticosteroids because of the risk of potentiating SCC.
Lichen sclerosus et atrophicus responding to methotrexate
TLDR
A case of extensive extragenital LS that responded remarkably well to low-dose methotrexate, having failed recognized topical therapies, and remission was maintained at follow-up 6 months later.
High incidence of lichen sclerosus in patients with squamous cell carcinoma of the penis
TLDR
There appears to be a definite association between SCC of the penis and the presence of LS, similar to that reported between LS and vulval SCC in women.
...
1
2
3
4
5
...